Mutations and copy number changes in NF1, CDKN2A/B, SUZ12, EED, and/or TP53 are found in most MPNST regardless of NF1 diagnosis; however, other signaling pathways have been implicated. This evidence concerns the gene TP53 and malignant peripheral nerve sheath tumor.